• 

  FDA Delays Aducanumab Decision
• 

  New Documentary Explores the Human and Financial Cost of Dementia
• 

  Legal Planning After a Dementia Diagnosis: 3 Things You Need To Know
• 

  Not All in Our Heads: Clearing the Haze of Pandemic ‘Brain Fog’
• 

  Super Agers’ Increased Alzheimer’s Resistance
• 

  What Happens If Aducanumab Wins FDA Approval? It’s Complicated
• 

  Considering Genetic Testing for Alzheimer’s? 3 Things to Know
• 

  Mary Lou Grace Robison: Through Art, Honoring a Loved One With Dementia
• 

  How to Manage Life After a Dementia Diagnosis: 3 Things You Need to Know
• 

  Now Under FDA Review: Potential First Treatment for Dementia-Related Psychosis
• 

  Navigating Conservatorship for Families With a Close One With Dementia
• 

  Detecting Concussions Could One Day Be as Simple as a Saliva Swab
• 

  Experimental Alzheimer’s Drug Donanemab Looks Promising in Phase 2 Trial
• 

  The Human Brain Bears an Uncanny Resemblance to the Universe
• 

  Dr. Erin Foff & Chris Schwilk: Navigating Dementia’s Hallucinations and Delusions

Previous868788Next